Pancreatic response in healthy dogs fed diets of various fat compositions

Department of Veterinary Clinical Sciences, Murdoch University, Perth, WA, Australia 6150.
American Journal of Veterinary Research (Impact Factor: 1.34). 05/2009; 70(5):614-8. DOI: 10.2460/ajvr.70.5.614
Source: PubMed


To indirectly assess the pancreatic response in healthy dogs that were fed diets of different fat compositions with or without supplemental pancreatic enzymes and medium-chain triglycerides (MCTs).
10 healthy adult dogs.
Dogs were fed 4 diets once in random order at 1-week intervals; food was withheld from the dogs for > or = 12 hours prior to the feeding of each diet. Diets A and B contained 16% and 5% crude fat, respectively; diet C was composed of diet A with pancreatic enzymes; and diet D was composed of diet B with pancreatic enzymes and MCTs. Serum canine trypsin-like immunoreactivity (cTLI) and canine pancreatic lipase immunoreactivity (cPLI) concentrations were measured before (0 hours) and at 1 to 2 and 6 hours after feeding. Serum gastrin concentration was measured at 0 hours and at 5 to 10 minutes and 1 to 2 hours after feeding. A gastrin assay validation study was performed to confirm accuracy of test results in dogs. Data were analyzed by use of a repeated-measures general ANOVA.
Serum cTLI, cPLI, or gastrin concentrations in the dogs did not differ among the different diets fed, among dogs, or over time. When multiple comparisons were analyzed, diet D caused the least amount of measurable pancreatic response, although this difference was not significant.
Results did not indicate a significant effect of dietary fat content or addition of supplemental MCT oil or pancreatic enzymes in diets on serum cTLI, cPLI, or gastrin concentrations in healthy dogs.

13 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: CNT thin film sensors have been prepared by PECVD techniques on Si/Si<sub>3</sub>N<sub>4</sub> micromachined substrates. The role of the preparation conditions on the intrinsic electrical properties of the CNTs (i.e. metallic or semiconductor nature) the role of the structural defects on the CNT gas response (i.e. sensitivity, selectivity and stability) the interaction mechanisms of oxidizing and reducing molecules with the CNT surface (i.e physisorption or chemisorption), are analysed and discussed by means of experimental measurements (microstructural and electrical characterizations) and theoretical simulations (density functional calculations). CNT films demonstrated their fitness for oxidizing gases monitoring (NO<sub>2</sub> and O<sub>3</sub>), had good selectivity when water vapor and reducing gases are the interfering species, and good stability. Surface modifications and hybrid CNT structures are presented as possible routes to improve gas response.
    Sensors, 2004. Proceedings of IEEE; 11/2004
  • [Show abstract] [Hide abstract]
    ABSTRACT: The putative role of the gut in amplification of systemic inflammation in acute pancreatitis is gaining credence, and intraluminal nutrition has been shown to decrease inflammation in experimental models of pancreatitis. Prepyloric feeding often is used in people with acute pancreatitis, but has not been evaluated in dogs. Early intervention with enteral nutrition (EN) delivered proximal to the pylorus will be well tolerated in dogs with acute pancreatitis and provide justification for further larger trials. Ten dogs with severe acute pancreatitis in an open-label, prospective pilot study. Dogs were treated with plasma transfusion and standard care, and then consecutively assigned to receive either EN via esophagostomy tube feeding or parenteral nutrition (PN). Outcome was used to determine optimal study size for future studies, and complications were compared between the 2 groups. A significantly greater number of vomiting or regurgitating episodes occurred in dogs receiving PN. The dogs receiving EN did not demonstrate any noticeable postprandial pain. There were more catheter-related complications in the PN group. There was no difference in outcome between the 2 treatments, and 43 dogs for each treatment would be required in future studies to determine a difference in outcome. Early EN delivered proximal to the pylorus is well tolerated in dogs with severe pancreatitis and resulted in fewer complications than PN. Prospective trials in a larger cohort are justified to fully establish the potential benefit of early EN, preferably compared with minimal enteral nutrition.
    Journal of Veterinary Internal Medicine 03/2011; 25(3):419-25. DOI:10.1111/j.1939-1676.2011.0703.x · 1.88 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The panel of laboratory tests available for diagnosis of gastrointestinal (GI) diseases in dogs and cats is wide, and, recently, several new tests have been developed. This article will focus on advances in laboratory tests that are available for the general practitioner for diagnosis of GI diseases. Laboratory tests for diagnosis of gastric and intestinal infectious diseases include fecal parasite screening tests, enzyme-linked immunosorbent assays for parvoviral enteritis, and some specific bacterial tests like fluorescent in situ hybridization for identification of specific bacteria attached to the intestinal epithelial cells. Serum concentrations of folate and cobalamin are markers of intestinal absorption, but are also changed in exocrine pancreatic insufficiency and intestinal bacterial overgrowth. Hypocobalaminemia is common in GI and pancreatic disease. Decreased serum trypsin-like immunoreactivity is a very sensitive and specific test for the diagnosis of exocrine pancreatic insufficiency in dogs and cats. Serum pancreatic lipase is currently the most sensitive and specific test to identify pancreatic cell damage and acute pancreatitis. However, serum canine pancreas-specific lipase is less sensitive in canine chronic pancreatitis. Increased serum trypsin-like immunoreactivity is also specific for pancreatic damage but is less sensitive. It is very likely that further studies will help to better specify the role of these new tests in the diagnosis of canine and feline pancreatic diseases.
    Topics in Companion Animal Medicine 05/2011; 26(2):86-97. DOI:10.1053/j.tcam.2011.02.005 · 1.41 Impact Factor
Show more